BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
4.359
-0.111 (-2.49%)
Jul 21, 2025, 1:10 PM - Market open
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $19.05 million as of July 21, 2025. Its market cap has decreased by -59.60% in one year.
Market Cap
19.05M
Enterprise Value
5.04M
1-Year Change
-59.60%
Ranking
Category
Stock Price
$4.36
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $19.05M, a decrease of -43.65%. That is a compound annual growth rate of -3.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |